title: Functional discontinuities in prothymosin alpha caused by caspase cleavage in apoptotic cells.
abstract: Our study examines the effect of apoptosis on prothymosin alpha, an abundant, nuclear protein intimately involved with proliferation of all mammalian cells. When HeLa cells were treated with actinomycin D, with etoposide, or with staurosporine following synchronization with hydroxyurea, they underwent apoptosis based on several specific criteria, including fragmentation of DNA and activation of specific caspases. Similarly treated NIH3T3 cells arrested and displayed no indicators of apoptosis. In HeLa, but not in NIH3T3 cells, prothymosin alpha levels declined precipitously and a truncated version of the protein was formed. The following observations implicate caspase activity: (1) The truncated polypeptide arose only in the treated HeLa cell cultures. (2) The appearance of the truncated polypeptide coincided with the activation of caspase 3 and the cleavage of poly(ADP-ribose) polymerase, a known caspase substrate. (3) Carbobenzoxy-DEVD-fluoromethylketone, a cell-permeable caspase 3 inhibitor, blocked cleavage and degradation of prothymosin alpha. (4) The same inhibitor, when added to mixed extracts of apoptotic and normal cells, prevented cleavage of intact prothymosin alpha. (5) Recombinant caspase 3 and, to a much lesser extent, caspase 7 truncated purified prothymosin alpha. (6) In HeLa cells, cleavage occurred at three overlapping caspase 3-like sites with the consensus sequence D-X-X-D and released 10 to 14 residues from the carboxyl terminus, including the core nuclear localization signal. Two immediate consequences of the cleavage were observed: truncated prothymosin alpha was no longer confined to the nucleus and it was deficient in phosphate. These data suggest that the disabling of prothymosin alpha is a significant event in apoptosis. J. Cell. Physiol. 182:256-268, 2000. Published 2000 Wiley-Liss, Inc.
authors.affiliation: Section on Genes and Gene Products, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
authors.forename: S A
authors.initials: SA
authors.lastname: Enkemann
authors.forename: R H
authors.initials: RH
authors.lastname: Wang
authors.forename: M W
authors.initials: MW
authors.lastname: Trumbore
authors.forename: S L
authors.initials: SL
authors.lastname: Berger
mesh_terms: D016475:3T3 Cells / Q000378:metabolism / Q000502:physiology; D000818:Animals; D017209:Apoptosis / Q000502:physiology*; D020169:Caspases / Q000378:metabolism*; D006367:HeLa Cells / Q000378:metabolism / Q000502:physiology; D006801:Humans; D051379:Mice; D010446:Peptide Fragments / Q000378:metabolism; D010766:Phosphorylation; D011498:Protein Precursors / Q000737:chemistry* / Q000502:physiology*; D013947:Thymosin / Q000031:analogs & derivatives* / Q000737:chemistry / Q000502:physiology; D014018:Tissue Distribution
chemical_list: D010446:Peptide Fragments; D011498:Protein Precursors; C040782:prothymosin alpha; D013947:Thymosin; D020169:Caspases